Bibliographies thématiques / Chronic Obdstructive Pulmonary Disease

Littérature scientifique sur le sujet « Chronic Obdstructive Pulmonary Disease »

Auteur : Grafiati

Publié le 11 mars 2023

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Chronic Obdstructive Pulmonary Disease ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Chronic Obdstructive Pulmonary Disease"

Russell, Richard, et Jayne Norcliffe. « Chronic obstructive pulmonary disease : management of chronic disease ». Medicine 36, n^o 4 (avril 2008) : 218–22. http://dx.doi.org/10.1016/j.mpmed.2008.01.010.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Russell, Richard, Jayne Norcliffe et Mona Bafadhel. « Chronic obstructive pulmonary disease : management of chronic disease ». Medicine 40, n^o 5 (mai 2012) : 262–66. http://dx.doi.org/10.1016/j.mpmed.2012.02.009.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Hambleton, Kirsty, Mona Bafadhel et Richard Russell. « Chronic obstructive pulmonary disease : management of chronic disease ». Medicine 44, n^o 5 (mai 2016) : 310–13. http://dx.doi.org/10.1016/j.mpmed.2016.02.019.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Ramakrishnan, Sanjay, Mona Bafadhel et Richard Russell. « Chronic obstructive pulmonary disease : management of chronic disease ». Medicine 48, n^o 5 (mai 2020) : 333–36. http://dx.doi.org/10.1016/j.mpmed.2020.02.002.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Schneider, Sandra M. « Chronic Obstructive Pulmonary Disease ». Emergency Medicine Clinics of North America 7, n^o 2 (mai 1989) : 237–54. http://dx.doi.org/10.1016/s0733-8627(20)30335-7.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

MacIntyre, Neil R. « Chronic Obstructive Pulmonary Disease ». Pharmacotherapy 24, n^o 5 Part 2 (mai 2004) : 33S—43S. http://dx.doi.org/10.1592/phco.24.7.33s.34756.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Penz, Erika, Michael K. Stickland et Brandie Walker. « Chronic obstructive pulmonary disease ». Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 5, n^o 2 (4 mars 2021) : 84–88. http://dx.doi.org/10.1080/24745332.2021.1901630.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Kotolová, Hana, et Tomáš Hammer. « Chronic obstructive pulmonary disease ». Praktické lékárenství 14, n^o 4 (15 décembre 2018) : 156–60. http://dx.doi.org/10.36290/lek.2018.030.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Laine, Christine. « Chronic Obstructive Pulmonary Disease ». Annals of Internal Medicine 148, n^o 5 (4 mars 2008) : ITC3. http://dx.doi.org/10.7326/0003-4819-148-5-200803040-01003.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Fehrenbach, Chris. « Chronic obstructive pulmonary disease ». Nursing Standard 17, n^o 10 (20 novembre 2002) : 45–51. http://dx.doi.org/10.7748/ns2002.11.17.10.45.c3302.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Thèses sur le sujet "Chronic Obdstructive Pulmonary Disease"

McAllister, David Anthony. « Chronic obstructive pulmonary disease, pulmonary function and cardiovascular disease ». Thesis, University of Edinburgh, 2011. http://hdl.handle.net/1842/5615.

Texte intégral

Résumé :

Cardiovascular disease is common in Chronic Obstructive Pulmonary Disease (COPD), and forced expiratory volume in one second (FEV1) independently predicts cardiovascular morbidity and mortality. Pathological changes in the systemic vasculature have been proposed as potential mechanisms linking COPD to cardiovascular disease, and patients with COPD may be at increased risk of acute myocardial infarction during acute exacerbations. Notwithstanding causation, FEV1 may be a useful prognostic marker in patients undergoing cardiac surgery. This thesis examined these three aspects of cardiovascular co-morbidity in relation to COPD and FEV1. In 2,241 consecutive cardiac surgery patients, FEV1 was associated with length of hospital stay (p<0.001) and mortality (p<0.001) adjusting for age, sex, height, body mass index, socioeconomic status, smoking, cardiovascular risk factors, chronic pulmonary disease, and type/urgency of surgery. In a survey of Scottish Respiratory Consultants there was no consensus regarding the investigation and management of acute coronary syndrome in exacerbation of COPD. In a case-series of 242 patients with exacerbations 2.5% (95% CI 1.0 to 5.6%) had chest pain, raised serum troponin and serial electrocardiogram changes suggestive of acute coronary syndrome. However, over half reported chest pain, while raised troponin was not associated with chest pain or serial ECG changes. Carotid-radial pulse wave velocity (PWV), aortic distensibility, and aortic calcification were measured to assess the relationship of the systemic vasculature to FEV1 and emphysema severity on CT. In adjusted analyses, emphysema was associated with PWV in patients with COPD (p = 0.006) and, in population based samples, with extent of distal aortic calcification (p=0.02) but not with aortic distensibility (p=0.60). This thesis found that FEV1 was associated with mortality and length of hospital stay in patients undergoing cardiac surgery, and that chest pain and raised troponin were common but unrelated in exacerbation of COPD. In the vascular studies distal but not proximal vascular pathology was associated with FEV1, and if COPD is truly related to systemic arterial disease, the distal arterial tree is implicated.

Styles APA, Harvard, Vancouver, ISO, etc.

Murphy, Nicola. « Chronic obstructive pulmonary disease and anxiety ». Thesis, Coventry University, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.368862.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Solomon, Brahm Kevin. « Psychological Aspects of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease ». Thesis, Université d'Ottawa / University of Ottawa, 2016. http://hdl.handle.net/10393/34292.

Texte intégral

Résumé :

As a leading cause of disability that often leads to death, chronic obstructive pulmonary disease (COPD) can be characterized as both a chronic illness and a life-threatening one. As a result, the experience of individuals with COPD can include psychological concerns that are associated with both rehabilitation and palliative care. At the same time, the often-uncertain trajectory of COPD obscures a clear transition from rehabilitation to palliative care. It is not surprising, therefore, that treatments aimed at addressing patients’ rehabilitative and palliative needs largely proceed independently of each other. This dissertation contains two studies conducted with patients participating in a pulmonary rehabilitation program for COPD (N = 242). Separately, each study stems from a research tradition grounded in either the rehabilitative or palliative approach to treatment. Together, the studies highlight an opportunity for a model of more integrated care. Study 1 is derived from the rehabilitation literature and focuses on the issue of “catastrophizing” about breathlessness. Catastrophizing is characterized by a magnification of a symptom’s threat value, rumination about its perceived negative impact, and a sense of helplessness in addressing it. In some medical conditions with a primary symptom, such as chronic pain, catastrophizing demonstrates a strong relationship with the development of disability. Study 1 examines whether this relationship is found in the context of breathlessness. The study also reports the initial validation of the Breathlessness Catastrophizing Scale (BCS) as a means of assessing this phenomenon. Study 2 has its conceptual basis in the palliative care literature and highlights patients’ existential concerns around loss of dignity. Loss of dignity is a central construct in recent health care debates, because it is a primary reason underlying the requests of terminally ill individuals to seek medically hastened deaths (i.e., euthanasia or assisted suicide). Until now, however, loss of dignity has only been examined among patients with cancer. Study 2 examines whether loss of dignity is as prevalent among those with advanced COPD, and whether it improves with treatment. In Study 1 the BCS was found to be a reliable measure of breathlessness catastrophizing, with good convergent validity and sensitivity to change. Interestingly, it appears that breathlessness catastrophizing need not be a barrier to functional improvement in COPD. In Study 2, a “fractured” sense of dignity was found among 13% of patients with advanced COPD, suggesting that it is at least as prevalent as among those receiving palliative cancer care. It was also evident that loss of dignity is amenable to change with appropriate rehabilitation. This finding is important for societal debates regarding the provision of medically hastened deaths, which are often described as offering “death with dignity”. Together these studies demonstrate that in an interdisciplinary environment, such as the pulmonary rehabilitation program, not only is collaboration possible, but the distinct rehabilitative and palliative needs of patients can be met.

Styles APA, Harvard, Vancouver, ISO, etc.

Greening, Neil James. « Early pulmonary rehabilitation for exacerbations of chronic obstructive pulmonary disease ». Thesis, University of Leicester, 2014. http://hdl.handle.net/2381/29155.

Texte intégral

Résumé :

Exacerbations are key events in the natural history of chronic obstructive pulmonary disease (COPD), with limited recovery of physical performance, and the highest cause of readmission in the UK. This thesis explores the impact of exacerbations in COPD and chronic respiratory disease. In the first study I have investigated the effects of an early rehabilitation intervention on healthcare utilisation, strength and exercise capacity by conducting a large randomised control trial. Using a sub-group of this cohort I have then explored factors that predict hospital readmission. Finally I have conducted a study of single leg neuromuscular electrical stimulation (NMES) in stable COPD, alongside a resistance training group. No difference was seen following early rehabilitation in hospitalisation, healthcare utilisation or physical performance. A number of unexpected findings were noted, including an increase in 12 month mortality in the intervention group and large functional recovery in the usual care group. Using multivariate analysis three risk factors for hospital readmission were identified, including quadriceps cross sectional area, using ultrasound. In the stable state NMES was seen to significantly increase muscle mass from baseline, comparable to changes seen using resistance training. In summary early rehabilitation in chronic respiratory disease does not impact on future hospitalisation. Identification of those with rehabilitation potential is required as the hospitalised population represent a frail group, with advanced disease.

Styles APA, Harvard, Vancouver, ISO, etc.

John, Michelle. « The extra-pulmonary effects of chronic obstructive pulmonary disease (COPD) ». Thesis, University of Nottingham, 2014. http://eprints.nottingham.ac.uk/14405/.

Texte intégral

Résumé :

Rationale Cardiovascular disease (CVD) is a leading cause of mortality in patients with COPD. Aortic stiffness, measured using aortic pulse wave velocity (PWV), an independent, non-invasive, predictor of CV risk; and inflammatory markers are increased in COPD. Screening tools for community based identification of increased CVD risk, and a proactive approach to addressing primary prevention of CVD is needed. Statins modulate aortic stiffness and are anti-inflammatory, but are not currently used for primary prevention in COPD. Objectives Proof of principle double-blind Randomised Control Trial (RCT) to determine if six weeks simvastatin 20mg od reduces aortic stiffness, systemic and airway inflammation in COPD. Cross-sectional pilot study comparing a non-invasive measure of oxidative stress (skin “AGE”) in COPD and controls, to lung function and aortic stiffness. Methods Stable patients (n=70) were randomised to simvastatin or placebo treatment. Pre- and post-treatment aortic stiffness, blood pressure, spirometry, circulating inflammatory mediators and lipids were measured; airway inflammatory markers were performed where possible. Predefined subgroup analysis was performed where baseline aortic PWV >10m/s. For the cross-sectional study stable COPD patients (n=84) and controls (n=36) had lung function, arterial stiffness and skin AGE measured. Results In the RCT the active group achieved significantly lower total cholesterol, but no significant drop in aortic PWV compared to placebo group: -0.7(95%CI -1.8,0.5)m/s, p=0.24; or inflammatory markers. In those with higher baseline aortic PWV, n=22, aortic PWV improved in the active group compared to placebo: -2.8(-5.2,-0.3)m/s, p=0.03. Skin AGE was increased in COPD compared to controls, inversely related to lung function, and directly related to aortic stiffness. Conclusions We could not detect any significant difference in the change in aortic PWV in patients with COPD taking simvastatin compared to placebo. We did, however, report a significant and clinically relevant reduction in aortic PWV in those with high baseline aortic stiffness, suggesting a potential for statins to reduce CV morbidity in high risk individuals. The pilot cross-sectional study suggests there is an indication to assess the potential role of skin AGE in patients with COPD as a non-invasive measure of CV risk.

Styles APA, Harvard, Vancouver, ISO, etc.

Roos-Engstrand, Ester. « T cells in chronic obstructive pulmonary disease ». Doctoral thesis, Umeå : Umeå university, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-33677.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Stevenson, Nicola Jane. « Lung mechanics in chronic obstructive pulmonary disease ». Thesis, University of Liverpool, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.432977.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Wodehouse, Theresa. « Ciliary aspects of chronic sino-pulmonary disease ». Thesis, Imperial College London, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.271952.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Al-shair, Khaled. « Systemic Manifestations of Chronic Obstructive Pulmonary Disease ». Thesis, University of Manchester, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.509061.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Revill, Susan M. « Endurance exercise in chronic obstructive pulmonary disease ». Thesis, Loughborough University, 1997. https://dspace.lboro.ac.uk/2134/15388.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Livres sur le sujet "Chronic Obdstructive Pulmonary Disease"

Nakamura, Hiroyuki, et Kazutetsu Aoshiba, dir. Chronic Obstructive Pulmonary Disease. Singapore : Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-0839-9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Nici, Linda, et Richard ZuWallack, dir. Chronic Obstructive Pulmonary Disease. Totowa, NJ : Humana Press, 2012. http://dx.doi.org/10.1007/978-1-60761-673-3.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Stockley, Robert A., Stephen I. Rennard, Klaus Rabe et Bartolome Celli, dir. Chronic Obstructive Pulmonary Disease. Oxford, UK : Blackwell Publishing Ltd, 2007. http://dx.doi.org/10.1002/9780470755976.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Calverley, P. M. A., et N. B. Pride, dir. Chronic Obstructive Pulmonary Disease. Boston, MA : Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-4525-9.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

National Heart, Lung, and Blood Institute., dir. Chronic obstructive pulmonary disease. [Bethesda, Md.?] : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

1939-, Hodgkin John E., dir. Chronic obstructive pulmonary disease. Philadelphia : W. B. Saunders, 1990.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Currie, Graeme P. Chronic obstructive pulmonary disease. Oxford : Oxford University Press, 2009.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

1932-, Petty Thomas L., dir. Chronic obstructive pulmonary disease. 2^e éd. New York : Dekker, 1985.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Rochester, Carolyn L. Chronic obstructive pulmonary disease. Philadelphia : W.B. Saunders Co., 2000.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Celli, Bartolome R., et Stephen I. Rennard. Chronic obstructive pulmonary disease. Philadelphia, Pennsylvania : Saunders, an imprint of Elsevier, Inc., 2012.

Trouver le texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Chapitres de livres sur le sujet "Chronic Obdstructive Pulmonary Disease"

Farver, Carol, Subha Ghosh, Thomas Gildea et Charles D. Sturgis. « Chronic Obstructive Pulmonary Diseases ». Dans Pulmonary Disease, 145–60. Cham : Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-47598-7_11.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Clark, C. J. « Pulmonary Rehabilitation ». Dans Chronic Obstructive Pulmonary Disease, 527–45. Boston, MA : Springer US, 1995. http://dx.doi.org/10.1007/978-1-4899-4525-9_21.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Troosters, Thierry. « Cardiovascular Disease ». Dans Chronic Obstructive Pulmonary Disease, 47–59. Totowa, NJ : Humana Press, 2011. http://dx.doi.org/10.1007/978-1-60761-673-3_4.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Pratt, Philip C. « Emphysema and Chronic Airways Disease ». Dans Pulmonary Pathology, 651–69. New York, NY : Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4757-3932-9_24.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Pratt, Philip C. « Emphysema and Chronic Airways Disease ». Dans Pulmonary Pathology, 847–65. New York, NY : Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4757-3935-0_26.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Underwood, David C. « Chronic obstructive pulmonary disease ». Dans In Vivo Models of Inflammation, 159–77. Basel : Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-7775-6_7.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Bertholet, Renette, et Inessa McIntyre. « Chronic Obstructive Pulmonary Disease ». Dans Patient Assessment in Clinical Pharmacy, 213–24. Cham : Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-11775-7_16.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Stucky, Kirk, et Jeff Greenblatt. « Chronic Obstructive Pulmonary Disease ». Dans Comprehensive Handbook of Clinical Health Psychology, 277–300. Hoboken, NJ, USA : John Wiley & Sons, Inc., 2012. http://dx.doi.org/10.1002/9781118269657.ch12.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Kozora, Elizabeth, et Karin F. Hoth. « Chronic Obstructive Pulmonary Disease ». Dans Encyclopedia of Clinical Neuropsychology, 782–85. Cham : Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_545.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Franco, S., et Marilyn Glassberg. « Chronic Obstructive Pulmonary Disease ». Dans Encyclopedia of Women’s Health, 262–64. Boston, MA : Springer US, 2004. http://dx.doi.org/10.1007/978-0-306-48113-0_88.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Actes de conférences sur le sujet "Chronic Obdstructive Pulmonary Disease"

Balasubramanian, A., T. M. Kolb, R. L. Damico, P. M. Hassoun, M. C. McCormack et S. C. Mathai. « Characterization of Chronic Obstructive Pulmonary Disease-Pulmonary Hypertension ». Dans American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5961.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Calancea, Valentin, Eudochia Terna, Tatiana Dumitras, Doina Barba, Irina Cosciug et Sergiu Matcovschi. « Pulmonary haemodynamic disorders in chronic obstructive pulmonary disease ». Dans ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2464.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Jakimova, Marina Artemovna, Natalya Karpina, Olga Gordeeva et Rasul Asanov. « Comorbidity : pulmonary tuberculosis and chronic obstructive pulmonary disease ». Dans ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2969.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Sokolovic, Irena, Jelena Knezevic, Sanja Popovic-Grle, Andrea Vukic Dugac, Gordana Bubanovic, Mateja Jankovic Makek, Ana Hecimovic, Gzim Redzepi, Miroslav Samarzija et Marko Jakopovic. « Chronic obstructive pulmonary disease and comorbidities ». Dans Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa1123.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Nadia, Fettal, Beziou Yamina et Taleb Abdessamed. « Diabetes and chronic obstructive pulmonary disease ». Dans ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa4319.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Walid, Feki, Chaabouni Malek, Ketata Wajdi, Moussa Nadia, Bahloul Najla, Msaad Sameh, Kotti Amina et al. « Chronic pain in patients with chronic obstructive pulmonary disease ». Dans ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4012.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Mirdamadi, Mahsa, Hosnollah Sadeghi, Ali Safaei et Mahmood Salesi. « Postoperative Pulmonary Complications in Bronchial Asthma/Chronic Obstructive Pulmonary Disease/Non-Pulmonary Disease Patients ». Dans ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa4061.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Gupta, V., D. Singh, S. Pandit, P. Bhadoria et D. P. Bhadoria. « Prevalence of Asthma Chronic Obstructive Pulmonary Disease Overlap Syndrome in Indian Patients of Chronic Obstructive Pulmonary Disease ». Dans American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4746.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Gill, K., et D. Lee. « More than Just Chronic Obstructive Pulmonary Disease ». Dans American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6449.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

DeMeo, DL, CP Hersh, B. Klanderman, AA Litonjua et EK Silverman. « Aging Genes and Chronic Obstructive Pulmonary Disease. » Dans American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3000.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Rapports d'organisations sur le sujet "Chronic Obdstructive Pulmonary Disease"

Lin, Chun-Long. Prevalence and prognosis of pulmonary hypertension in patients with chronic kidney disease. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, février 2023. http://dx.doi.org/10.37766/inplasy2023.2.0051.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Wang, Yanping, Mingru Huang, Liping Tang, Lingxia Xu, Jiangfeng Wu, Fei Wang et Ying Zhang. Moxibustion for stable chronic obstructive pulmonary disease : a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, avril 2021. http://dx.doi.org/10.37766/inplasy2021.4.0047.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Czerwaty, Katarzyna, Karolina Dżaman, Krystyna Maria Sobczyk et Katarzyna Irmina Sikrorska. The Overlap Syndrome of Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease : A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, novembre 2022. http://dx.doi.org/10.37766/inplasy2022.11.0077.

Texte intégral

Résumé :

Review question / Objective: To provide the essential findings in the field of overlap syndrome of chronic obstructive pulmonary disease and obstructive sleep apnea, including prevalence, possible predictors, association with clinical outcomes, and severity compared to both chronic obstructive pulmonary disease and obstructive sleep apnea patients. Condition being studied: OSA is characterized by complete cessation (apnea) or significant decrease (hy-popnea) in airflow during sleep and recurrent episodes of upper airway collapse cause it during sleep leading to nocturnal oxyhemoglobin desaturations and arousals from rest. The recurrent arousals which occur in OSA lead to neurocognitive consequences, daytime sleepiness, and reduced quality of life. Because of apneas and hypopneas, patients are experiencing hypoxemia and hypercapnia, which result in increasing levels of catecholamine, oxidative stress, and low-grade inflammation that lead to the appearance of cardio-metabolic consequences of OSA. COPD is a chronic inflammatory lung disease defined by persistent, usually pro-gressive AFL (airflow limitation). Changes in lung mechanics lead to the main clini-cal manifestations of dyspnea, cough, and chronic expectoration. Furthermore, patients with COPD often suffer from anxiety and depression also, the risk of OSA and insomnia is higher than those hospitalized for other reasons. Although COPD is twice as rare as asthma but is the cause of death eight times more often.

Styles APA, Harvard, Vancouver, ISO, etc.

Feng, Zhenzhen, Xuanlin Li, Yang Xie et Jiansheng Li. Effectiveness of Tai Chi for Chronic obstructive Pulmonary Disease : Overview of Systematic Reviews and Meta-analyses. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, octobre 2020. http://dx.doi.org/10.37766/inplasy2020.10.0114.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Zhou, Wen. Does benralizumab effectively treat chronic obstructive pulmonary disease ? a protocol of systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review Protocols, avril 2020. http://dx.doi.org/10.37766/inplasy2020.4.0039.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Xue, Jiali, Xiaona Zhang, Hongyan Lu, Xirui Jiang, Fang Yu et Pengfei Yang. Nonpharmacological interventions for chronic obstructive pulmonary disease-related fatigue : A systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, septembre 2022. http://dx.doi.org/10.37766/inplasy2022.9.0072.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Barros-Poblete, Marisol, Rodrigo Torres-Castro, Mauricio Henríquez, Anita Guequen, Isabel Blanco et Carlos Flores. Dysbiosis as a prognostic factor for clinical worsening in chronic respiratory disease : A systematic review and metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, avril 2022. http://dx.doi.org/10.37766/inplasy2022.4.0089.

Texte intégral

Résumé :

Review question / Objective: Is dysbiosis a prognostic factor for clinical worsening in patients with chronic respiratory diseases?. Condition being studied: Dysbiosis, defined as changes in the quantitative and qualitative composition of the microbiota. Eligibility criteria: Over 18 years old adult patients with chronic respiratory diseases clinical diagnosis (cystic fibrosis, chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, interstitial lung disease, sarcoidosis, bronchiectasis, non-CF bronchiectasis, pulmonary hypertension) according to the International Statistical Classification of Diseases and Related Health Problems (ICD) from OMS) and international guidelines of each disease.

Styles APA, Harvard, Vancouver, ISO, etc.

Lei, Yuping, Meili Wang, Guiqiang Sun, Yong Liu, Yapei Yang et Dong Hao. Chinese herbal medicine injections (CHMIs) for chronic pulmonary heart disease : protocol for a Bayesian network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, décembre 2020. http://dx.doi.org/10.37766/inplasy2020.12.0004.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Li, Shuyao, Wenshuang Zhang et Tong Guan. Effect of Bifidobacterium Bifidum for Chronic Obstructive Pulmonary Disease in China : A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, juin 2022. http://dx.doi.org/10.37766/inplasy2022.6.0023.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Xie, Rongfang, Chunyan Huang, Miaomiao Li et Zhihui Lan. Yiqi Wenyang Huoxue Method in Treating Stable Chronic Obstructive Pulmonary Disease : A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, août 2022. http://dx.doi.org/10.37766/inplasy2022.8.0011.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!